Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastases
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (3) , 289-294
- https://doi.org/10.1016/0959-8049(94)90243-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.Journal of Clinical Oncology, 1992
- Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal veinCancer, 1987
- Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated prefused rat liverCancer Chemotherapy and Pharmacology, 1987
- Intrahepatic arterial administration of 4′epidoxorubicin (epirubicin) in advanced cancer patients. A pharmacokinetic studyEuropean Journal of Cancer and Clinical Oncology, 1986
- Intrahepatic and intravenous administration of adriamycin—A Comparative pharmacokinetic study in patients with malignant liver tumoursMedical Oncology and Tumor Pharmacotherapy, 1985
- Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.Journal of Clinical Oncology, 1985
- Relationship between the intracellular level and growth inhibition of a new anthracycline 4′O-tetrahydropyranyl-adriamycin in friend leukemia cell variantsLeukemia Research, 1985
- Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology reportCancer, 1978